Dr. Varga is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000- Is this information wrong?
Summary
- I received my MD from New York University. Following Medicine residency at Rhode Island Hospital, trained in Rheumatology at Boston University, and then completed a basic research post-doc at the University of Pennsylvania
I moved to the Midwest in 1995, and joined the faculty at Northwestern University in 2004. I founded the Scleroderma Program and run a basic/translational research lab focusing on fibrosis and precision medicine
Education & Training
- University of Pennsylvania Health SystemFellowship, Rheumatology, 1985 - 1987
- Boston University Medical CenterFellowship, Rheumatology, 1983 - 1985
- Brown UniversityResidency, Internal Medicine, 1980 - 1983
- New York University School of MedicineClass of 1980
Certifications & Licensure
- MI State Medical License 2020 - 2026
- IL State Medical License 1995 - 2020
- PA State Medical License 1985 - 1996
Awards, Honors, & Recognition
- Member Association of American Physicians
- Member AOA
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Join now to see all
Publications & Presentations
PubMed
- TGF-β1 Drives Integrin-Dependent Pericyte Migration and Microvascular Destabilization in Fibrotic Disease.Amanda S Pellowe, Michelle J Wu, Tae-Yun Kang, Tracy D Chung, Adrian Ledesma-Mendoza, Andre Levchenko, Anjelica L Gonzalez, Erica Herzog, Ian Odell, John Varga> ;The American Journal of Pathology. 2024 Mar 26
- Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis.Feiyang Ma, Pei-Suen Tsou, Mehrnaz Gharaee-Kermani, Olesya Plazyo, Xianying Xing, Joseph Kirma, Rachael Wasikowski, Grace A Hile, Paul W Harms, Yanyun Jiang, Enze Xing...> ;Nature Communications. 2024 Jan 3
- 1 citationsEmerging cellular and immunotherapies for systemic sclerosis: from mesenchymal stromal cells to CAR-T cells and vaccine-based approaches.Alain Lescoat, Hiroshi Kato, John Varga> ;Current Opinion in Rheumatology. 2023 Nov 1
- Join now to see all
Journal Articles
- Emerging Targets of Disease-Modifying Therapy for Systemic SclerosisElizabeth R Volkmann, John Varga, Nature
- Adipocyte-Specific Repression of PPAR-Gamma by NCoR Contributes to Scleroderma Skin FibrosisWarren Tourtellotte, Benjamin Korman, John Varga, BioMed Central
Other
- Pulmonary vascular disease in systemic sclerosis (scleroderma): TreatmentVarga J, Steen V
http://www.uptodate.com/contents/pulmonary-vascular-disease-in-systemic-sclerosis-scleroderma-treatm
UpToDate, Wolters Kluwer Health - 2012-04-23 - Scleroderma renal crisisVarga J, Fenves A
http://www.uptodate.com/contents/scleroderma-renal-crisis
UpToDate, Wolters Kluwer Health - 2013-04-12 - Eosinophilic fasciitisVarga J, Helfgott SM
http://www.uptodate.com/contents/eosinophilic-fasciitis
UpToDate, Wolters Kluwer Health - 2012-09-14 - Join now to see all
Press Mentions
- Could Getting Rid of Old Cells Turn Back the Clock on Aging?January 2nd, 2023
- How the Western Diet and Gut Bacteria Can Lead to Scarring, Vessel Damage in SclerodermaAugust 23rd, 2022
- PLG Nanoparticles Inhibit Skin and Lung Fibrosis by Targeting MARCO+ CellsMarch 8th, 2022
- Join now to see all
Professional Memberships
- Fellow
Hospital Affiliations
- Northwestern Memorial HospitalChicago, Illinois
- University of Michigan Medical CenterAnn Arbor, Michigan
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: